Clostridium difficile PCR ribotype 018, a successful epidemic genotype

Journal of Clinical Microbiology

Volumn 53, Issue 8, 2015, Pages 2575-2580

  Baldan, Rossella ^a   Trovato, Alberto ^a   Bianchini, Valentina ^a   Biancardi, Anna ^a   Cichero, Paola ^a   Mazzotti, Maria ^a   Nizzero, Paola ^a   Moro, Matteo ^a   Ossi, Cristina ^a   Scarpellini, Paolo ^a   Cirillo, Daniela Maria ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL TOXIN; BETA LACTAM ANTIBIOTIC; BINARY TOXIN; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; GENOMIC DNA; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CDTA GENE; CDTB GENE; CLINICAL PRACTICE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DRUG EXPOSURE; DRUG USE; EPIDEMIC; ERMB GENE; GENETIC ASSOCIATION; GENETIC SIMILARITY; GENOTYPE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; ITALY; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RIBOTYPING; TCDA GENE; TCDB GENE; TEACHING HOSPITAL; TOXIN ANALYSIS; AGED; CLASSIFICATION; CLOSTRIDIUM INFECTIONS; COLITIS; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; VERY ELDERLY;

CLOSTRIDIUM DIFFICILE;

AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLITIS; EPIDEMICS; FEMALE; HOSPITALS, TEACHING; HUMANS; ITALY; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; RIBOTYPING;

EID: 84938125686     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00533-15     Document Type: Article

References (45)

1. Dubberke ER, Olsen MA. 2012. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 55 (Suppl 2):S88-S92. http://dx.doi.org/10.1093/cid/cis335.
2. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, Kuijper EJ, Wilcox MH. 2010. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 23:529-549. http://dx.doi.org/10.1128/CMR.00082-09.
3. Ananthakrishnan AN. 2011. Clostridium difficile infection: epidemiology, risk factors, and management. Nat Rev Gastroenterol Hepatol 8:17-26. http://dx.doi.org/10.1038/nrgastro.2010.190.
4. Kuijper EJ, Coignard B, Tüll P, ESCMID study group for Clostridium difficile, EU Member States, European Centre for Disease Prevention and Control. 2006. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 12(Suppl 6):S2-S18.
5. Walker AS, Eyre DW, Wyllie DH, Dingle KE, Griffiths D, Shine B, Oakley S, O?Connor L, Finney J, Vaughan A, Crook DW, Wilcox MH, Peto TE. 2013. Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis 56: 1589-1600. http://dx.doi.org/10.1093/cid/cit127.
6. O?Connor JR, Johnson S, Gerding DN. 2009. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 136: 1913-1924. http://dx.doi.org/10.1053/j.gastro.2009.02.073.
7. Hunt JJ, Ballard JD. 2013. Variations in virulence and molecular biology among emerging strains of Clostridium difficile. Microbiol Mol Biol Rev 77:567-581. http://dx.doi.org/10.1128/MMBR.00017-13.
8. Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, Cairns M, Curran MD, Dodgson KJ, Green SM, Hardy KJ, Hawkey PM, Magee JG, Sails AD, Wren MW. 2012. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis 55:1056-1063. http://dx.doi.org/10.1093/cid/cis614.
9. Kuijper EJ, Barbut F, Brazier JS, Kleinkauf N, Eckmanns T, Lambert ML, Drudy D, Fitzpatrick F, Wiuff C, Brown DJ, Coia JE, Pituch H, Reichert P, Even J, Mossong J, Widmer AF, Olsen KE, Allerberger F, Notermans DW, Delmée M, Coignard B, Wilcox M, Patel B, Frei R, Nagy E, Bouza E, Marin M, Akerlund T, Virolainen-Julkunen A, Lyytikäinen O, Kotila S, Ingebretsen A, Smyth B, Rooney P, Poxton IR, Monnet DL. 2008. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe. Euro Surveill 13:pii-18942. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleID-18942.
10. Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW, Bergwerff AA, Dekker FW, Kuijper EJ. 2008. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47:1162-1170. http://dx.doi.org/10.1086/592257.
11. Smits WK. 2013. Hype or hypervirulence: a reflection on problematic C. difficile strains. Virulence 4:592-596. http://dx.doi.org/10.4161/viru.26297.
12. Lee JH, Lee Y, Lee K, Riley TV, Kim H. 2014. The changes of PCR ribotype and antimicrobial resistance of Clostridium difficile in a tertiary care hospital over 10 years. J Med Microbiol 63:819-823. http://dx.doi.org/10.1099/jmm.0.072082-0.
13. Arvand M, Hauri AM, Zaiss NH, Witte W, Bettge-Weller G. 2009. Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany. Euro Surveill 14:pii-19403. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleID-19403.
14. Taori SK, Wroe A, Poxton IR. 2013. Clostridium difficile infections in southeast Scotland: mortality and recurrence in a region without PCR ribotype 027. J Med Microbiol 62:1468-1477. http://dx.doi.org/10.1099/jmm.0.061093-0.
15. Borgmann S, Kist M, Jakobiak T, Reil M, Scholz E, von Eichel-Streiber C, Gruber H, Brazier JS, Schulte B. 2008. Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany. Euro Surveill 13:pii-19057. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleID-19057.
16. Baldan R, Cavallerio P, Tuscano A, Parlato C, Fossati L, Moro M, Serra R, Cirillo DM. 2010. First report of hypervirulent strains polymerase chain reaction ribotypes 027 and 078 causing severe Clostridium difficile infection in Italy. Clin Infect Dis 50:126-127. http://dx.doi.org/10.1086/649011.
17. Di Bella S, Paglia MG, Johnson E, Petrosillo N. 2012. Clostridium difficile 027 infection in Central Italy.BMCInfect Dis 12:370. http://dx.doi.org/10.1186/1471-2334-12-370.
18. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ, study group ECDIS. 2011. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377:63-73. http://dx.doi.org/10.1016/S0140-6736(10)61266-4.
19. Guastalegname M, Grieco S, Giuliano S, Falcone M, Caccese R, Carfagna P, D?ambrosio M, Taliani G, Venditti M. 2014. A cluster of fulminant Clostridium difficile colitis in an intensive care unit in Italy. Infection 42:585-589. http://dx.doi.org/10.1007/s15010-014-0597-1.
20. Spigaglia P, Barbanti F, Dionisi AM, Mastrantonio P. 2010. Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018. J Clin Microbiol 48:2892-2896. http://dx.doi.org/10.1128/JCM.02482-09.
21. Furci L, Baldan R, Bianchini V, Trovato A, Ossi C, Cichero P, Cirillo DM. 2015. A new role for human-defensin 5 in the fight against Clostridium difficile hypervirulent strains. Infect Immun 83:986-995. http://dx.doi.org/10.1128/IAI.02955-14.
22. Bauer MP, Kuijper EJ, van Dissel JT, European Society of Clinical Microbiology and Infectious Diseases. 2009. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 15:1067-1079. http://dx.doi.org/10.1111/j.1469-0691.2009.03099.x.
23. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK; Ad Hoc Clostridium difficile Surveillance Working group. 2007. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 28:140-145. http://dx.doi.org/10.1086/511798.
24. Langlois-Klassen D, Senthilselvan A, Chui L, Kunimoto D, Saunders LD, Menzies D, Long R. 2013. Transmission of Mycobacterium tuberculosis Beijing strains, Alberta, Canada, 1991 to 2007. Emerg Infect Dis 19: 701-711. http://dx.doi.org/10.3201/eid1905.121578.
25. Persson S, Torpdahl M, Olsen KE. 2008. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clin Microbiol Infect 14:1057-1064. http://dx.doi.org/10.1111/j.1469-0691.2008.02092.x.
26. Schmidt C, Löffler B, Ackermann G. 2007. Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile. Diagn Microbiol Infect Dis 59:1-5. http://dx.doi.org/10.1016/j.diagmicrobio.2007.03.009.
27. Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40:2562-2566.
28. Carman RJ, Genheimer CW, Rafii F, Park M, Hiltonsmith HF, Lyerly DM. 2009. Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea. Anaerobe 15:244-248. http://dx.doi.org/10.1016/j.anaerobe.2009.09.009.
29. Di Bella S, Musso M, Cataldo MA, Meledandri M, Bordi E, Capozzi D, Cava MC, Chiaradonna P, Prignano G, Petrosillo N. 2013. Clostridium difficile infection in Italian urban hospitals: data from 2006 through 2011. BMC Infect Dis 13:146. http://dx.doi.org/10.1186/1471-2334-13-146.
30. Vernaz N, Hill K, Leggeat S, Nathwani D, Philips G, Bonnabry P, Davey P. 2009. Temporal effects of antibiotic use and Clostridium difficile infections. J Antimicrob Chemother 63:1272-1275. http://dx.doi.org/10.1093/jac/dkp128.
31. Rupnik M, Wilcox MH, Gerding DN. 2009. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7:526-536. http://dx.doi.org/10.1038/nrmicro2164.
32. Kaier K, Hagist C, Frank U, Conrad A, Meyer E. 2009. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol 30:346-353. http://dx.doi.org/10.1086/596605.
33. Hensgens MP, Goorhuis A, Notermans DW, van Benthem BH, Kuijper EJ. 2009. Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. Euro Surveill 14:pii-19402. http://www.eurosurveill ance.org/ViewArticle.aspx?ArticleID-19402.
34. Belmares J, Johnson S, Parada JP, Olson MM, Clabots CR, Bettin KM, Peterson LR, Gerding DN. 2009. Molecular epidemiology of Clostridium difficile over the course of 10 years in a tertiary care hospital. Clin Infect Dis 49:1141-1147. http://dx.doi.org/10.1086/605638.
35. Brazier JS, Raybould R, Patel B, Duckworth G, Pearson A, Charlett A, Duerden BI, HPA Regional Microbiology Network. 2008. Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007 to 2008. Euro Surveill 13:pii-19000. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleID-19000.
36. Terhes G, Brazier JS, Urban E, Soki J, Nagy E. 2006. Distribution of Clostridium difficile PCR ribotypes in regions of Hungary. J Med Microbiol 55:279-282. http://dx.doi.org/10.1099/jmm.0.46141-0.
37. Sawabe E, Kato H, Osawa K, Chida T, Tojo N, Arakawa Y, Okamura N. 2007. Molecular analysis of Clostridium difficile at a university teaching hospital in Japan: a shift in the predominant type over a 5-year period. Eur J Clin Microbiol Infect Dis 26:695-703. http://dx.doi.org/10.1007/s10096-007-0355-8.
38. Walk ST, Micic D, Jain R, Lo ES, Trivedi I, Liu EW, Almassalha LM, Ewing SA, Ring C, Galecki AT, Rogers MA, Washer L, Newton DW, Malani PN, Young VB, Aronoff DM. 2012. Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis 55:1661-1668. http://dx.doi.org/10.1093/cid/cis786.
39. Cloud J, Noddin L, Pressman A, Hu M, Kelly C. 2009. Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. Clin Gastroenterol Hepatol 7:868-873. http://dx.doi.org/10.1016/j.cgh.2009.05.018.
40. Barbut F, Rupnik M. 2012. Editorial commentary: 027, 078, and others: going beyond the numbers (and away from the hypervirulence). Clin Infect Dis 55:1669-1672. http://dx.doi.org/10.1093/cid/cis790.
41. Pépin J, Valiquette L, Cossette B. 2005. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173:1037-1042. http://dx.doi.org/10.1503/cmaj.050978.
42. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, René P, Monczak Y, Dascal A. 2005. A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353:2442-2449. http://dx.doi.org/10.1056/NEJMoa051639.
43. Collins DA, Hawkey PM, Riley TV. 2013. Epidemiology of Clostridium difficile infection in Asia. Antimicrob Resist Infect Control 2:21. http://dx.doi.org/10.1186/2047-2994-2-21.
44. Han SH, Kim H, Lee K, Jeong SJ, Park KH, Song JY, Seo YB, Choi JY, Woo JH, Kim WJ, Kim JM. 2014. Epidemiology and clinical features of toxigenic culture-confirmed hospital-onset Clostridium difficile infection: a multicentre prospective study in tertiary hospitals of South Korea. J Med Microbiol 63:1542-1551. http://dx.doi.org/10.1099/jmm.0.070672-0.
45. Kim J, Seo MR, Kang JO, Kim Y, Hong SP, Pai H. 2014. Clinical characteristics of relapses and reinfections in Clostridium difficile infection. Clin Microbiol Infect 20:1198-1204. http://dx.doi.org/10.1111/1469-0691.12704.